C. Depre et al., Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction, J MOL CEL C, 32(6), 2000, pp. 985-996
Diabetes mellitus alters energy substrate metabolism and gene expression in
the heart. It is not known whether the changes in gene expression are an a
daptive or maladaptive process. To answer this question, we determined both
the time-course and the extent of the alteration of gene expession induced
by insulin-deficient diabetes. Transcript analysis with real-time quantita
tive polymerase chain reaction (PCR) was performed in rat hearts 1 week (ac
ute group) or 6 months (chronic group) after administration of streptozotoc
in (55 mg/kg). In the acute group, insulin-dependent diabetes induced a 55-
70% decrease of both glucose transporter 1 (GLUT1) and GLUT4 transcripts, a
slight decrease of liver-specific carnitine palmitoyltransferase I (CPT I)
, and no change in muscle-specific CPT I. The uncoupling protein UCP-3 incr
eased three-fold, with no change in UCP-2. These metabolic alterations were
accompanied by an isoform switching from the normally expressed alpha myos
in heavy chain (MHC) to the fetal isoform beta MHC mRNA, by a 50% decrease
of cardiac alpha-actin mRNA, a 30% decrease of the sarcoplasmic Ca+ +-ATPas
e mRNA, and a 50% decrease of muscle creatine kinase (P<0.01 v controls). A
ll genomic changes were also present in the chronic group. Genomic markers
of ventricular dysfunction [tumor necrosis factor alpha (TNF-alpha), induci
ble nitric oxide synthase, cyclo-oxygenase-2] were not affected by chronic
diabetes. In both groups, there were no changes in resting left ventricular
function by echocardiography, Conclusion: the heart adapts to insulin-defi
cient diabetes by a rapid and simultaneous response of multiple genes invol
ved in cardiac metabolism and function. This genomic adaptation resembles t
he adaptation of cardiac hypertrophy, remains stable over time, and does no
t lead to major contractile dysfunction. (C) 2000 Academic Press.